BIOMAT Database Logo BIOMAT Database Logo

Calcitonin in the treatment of transient osteoporosis of the hip. 2003

Thurayya K Arayssi, and Hussein A Tawbi, and Ihab M Usta, and Mukbil H Hourani
Departments of Internal Medicine, Obstetrics and Gynecology and Diagnostic Radiology, American University of Beirut, Beirut, Lebanon.

BACKGROUND Transient osteoporosis of the hip (TOH) is a rare clinical disorder of unknown etiology characterized by hip pain and functional disability that resolve spontaneously in 6-24 months. OBJECTIVE To report 2 patients with TOH during pregnancy who had rapid resolution of their illness with the use of calcitonin. To review the literature on TOH with special emphasis on its treatment. METHODS A MEDLINE search of studies published from 1966 to 2002 was performed to review treatment options for TOH and their effect on the natural history of the disease. RESULTS Our 2 patients developed hip pain during pregnancy with classical changes of TOH on MRI. Both patients received calcitonin, 1 during pregnancy and 1 postpartum with resolution of their symptoms within 6 to 9 weeks. Previous reports in the literature of treatment of TOH showed that antiresorptive agents (bisphosphonates and calcitonin) had shortened the duration of the illness compared with the natural history of the disease. CONCLUSIONS TOH is an under-recognized entity associated with pain and disability. The use of antiresorptive agents may be of help in reducing the duration of the disease. CONCLUSIONS To increase the recognition of TOH and to consider therapeutic interventions to shorten the duration of the disease.

UI MeSH Term Description Entries
D010024 Osteoporosis Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. Age-Related Osteoporosis,Bone Loss, Age-Related,Osteoporosis, Age-Related,Osteoporosis, Post-Traumatic,Osteoporosis, Senile,Senile Osteoporosis,Osteoporosis, Involutional,Age Related Osteoporosis,Age-Related Bone Loss,Age-Related Bone Losses,Age-Related Osteoporoses,Bone Loss, Age Related,Bone Losses, Age-Related,Osteoporoses,Osteoporoses, Age-Related,Osteoporoses, Senile,Osteoporosis, Age Related,Osteoporosis, Post Traumatic,Post-Traumatic Osteoporoses,Post-Traumatic Osteoporosis,Senile Osteoporoses
D010146 Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. Suffering, Physical,Ache,Pain, Burning,Pain, Crushing,Pain, Migratory,Pain, Radiating,Pain, Splitting,Aches,Burning Pain,Burning Pains,Crushing Pain,Crushing Pains,Migratory Pain,Migratory Pains,Pains, Burning,Pains, Crushing,Pains, Migratory,Pains, Radiating,Pains, Splitting,Physical Suffering,Physical Sufferings,Radiating Pain,Radiating Pains,Splitting Pain,Splitting Pains,Sufferings, Physical
D002116 Calcitonin A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults. Thyrocalcitonin,Calcitonin(1-32),Calcitrin,Ciba 47175-BA,Eel Calcitonin,Calcitonin, Eel,Ciba 47175 BA,Ciba 47175BA
D005260 Female Females
D006621 Hip Joint The joint that is formed by the articulation of the head of FEMUR and the ACETABULUM of the PELVIS. Acetabulofemoral Joint,Acetabulofemoral Joints,Hip Joints,Joint, Acetabulofemoral,Joint, Hip,Joints, Acetabulofemoral,Joints, Hip
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014057 Tomography, X-Ray Computed Tomography using x-ray transmission and a computer algorithm to reconstruct the image. CAT Scan, X-Ray,CT Scan, X-Ray,Cine-CT,Computerized Tomography, X-Ray,Electron Beam Computed Tomography,Tomodensitometry,Tomography, Transmission Computed,X-Ray Tomography, Computed,CAT Scan, X Ray,CT X Ray,Computed Tomography, X-Ray,Computed X Ray Tomography,Computerized Tomography, X Ray,Electron Beam Tomography,Tomography, X Ray Computed,Tomography, X-Ray Computer Assisted,Tomography, X-Ray Computerized,Tomography, X-Ray Computerized Axial,Tomography, Xray Computed,X Ray Computerized Tomography,X Ray Tomography, Computed,X-Ray Computer Assisted Tomography,X-Ray Computerized Axial Tomography,Beam Tomography, Electron,CAT Scans, X-Ray,CT Scan, X Ray,CT Scans, X-Ray,CT X Rays,Cine CT,Computed Tomography, Transmission,Computed Tomography, X Ray,Computed Tomography, Xray,Computed X-Ray Tomography,Scan, X-Ray CAT,Scan, X-Ray CT,Scans, X-Ray CAT,Scans, X-Ray CT,Tomographies, Computed X-Ray,Tomography, Computed X-Ray,Tomography, Electron Beam,Tomography, X Ray Computer Assisted,Tomography, X Ray Computerized,Tomography, X Ray Computerized Axial,Transmission Computed Tomography,X Ray Computer Assisted Tomography,X Ray Computerized Axial Tomography,X Ray, CT,X Rays, CT,X-Ray CAT Scan,X-Ray CAT Scans,X-Ray CT Scan,X-Ray CT Scans,X-Ray Computed Tomography,X-Ray Computerized Tomography,Xray Computed Tomography
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Thurayya K Arayssi, and Hussein A Tawbi, and Ihab M Usta, and Mukbil H Hourani
Transient regional osteoporosis of the hip treated with calcitonin.
January 1978, The Journal of rheumatology,
Thurayya K Arayssi, and Hussein A Tawbi, and Ihab M Usta, and Mukbil H Hourani
[Transient osteoporosis of the hip in pregnancy. Successful treatment with calcitonin: a case report].
October 2007, Zeitschrift fur Rheumatologie,
Thurayya K Arayssi, and Hussein A Tawbi, and Ihab M Usta, and Mukbil H Hourani
[Transient osteoporosis in pregnancy. Transient osteoporosis of the right hip].
May 2001, Praxis,
Thurayya K Arayssi, and Hussein A Tawbi, and Ihab M Usta, and Mukbil H Hourani
Transient hip osteoporosis.
March 2006, Orthopedics,
Thurayya K Arayssi, and Hussein A Tawbi, and Ihab M Usta, and Mukbil H Hourani
Transient osteoporosis of the hip.
April 2019, European journal of rheumatology,
Thurayya K Arayssi, and Hussein A Tawbi, and Ihab M Usta, and Mukbil H Hourani
Transient osteoporosis of the hip.
February 2012, JPMA. The Journal of the Pakistan Medical Association,
Thurayya K Arayssi, and Hussein A Tawbi, and Ihab M Usta, and Mukbil H Hourani
Transient osteoporosis of the hip.
April 1990, Orthopedics,
Thurayya K Arayssi, and Hussein A Tawbi, and Ihab M Usta, and Mukbil H Hourani
[Transient osteoporosis of the hip].
November 1993, Polski tygodnik lekarski (Warsaw, Poland : 1960),
Thurayya K Arayssi, and Hussein A Tawbi, and Ihab M Usta, and Mukbil H Hourani
Transient osteoporosis of the hip.
May 1999, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
Thurayya K Arayssi, and Hussein A Tawbi, and Ihab M Usta, and Mukbil H Hourani
Transient osteoporosis of the hip.
January 1999, International orthopaedics,
Copied contents to your clipboard!